Roundup settlement expected before Christmas, Bayer CEO says

Nov 3 (Reuters) - German ‌drugs and ​agrochemicals ​group Bayer is expecting a $7.25 billion settlement on its Roundup weedkiller ‌to come before Christmas, CEO Bill ⁠Anderson said on Tuesday.

The company is seeking to ‌resolve tens of thousands ‌of Roundup lawsuits through the proposed settlement, which is under review by a Missouri ​state court judge in St. Louis.

• "It could be any week now," Anderson ⁠said in a press call following the company's results, adding ​there would be a much smaller number of individual cases after the ​settlement.

• Bayer is facing approximately ‌65,000 claims in US state and federal courts from plaintiffs who ⁠say they developed non-Hodgkin lymphoma and other forms of cancer after using Roundup at ⁠home or on the job.

• Following a Supreme Court ​victory in June, Bayer moved its US Roundup business into a unit dubbed Ruveon and internally separated ‌it from the rest of the organisation.

• Bayer has said that ‌decades of studies have shown glyphosate, ⁠Roundup's active ingredient, ‌is safe and ​does not cause cancer.

(Reporting by Tristan Veyet in Gdansk, editing by Thomas ‌Seythal)

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• China's Baidu launches AI model simulating road environment for robotaxis
• Pfizer raises 2026 forecasts as Eliquis, cancer drugs drive Q3 beat
• Thomson Reuters posts higher third-quarter revenue, lifts forecast